Last reviewed · How we verify

Lipoplus + Omegaven — Competitive Intelligence Brief

Lipoplus + Omegaven (Lipoplus + Omegaven) competitive landscape: 1 comparator, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Intravenous lipid emulsion. Area: Nutrition support / Critical care.

marketed Intravenous lipid emulsion Nutrition support / Critical care Small molecule Live · refreshed every 30 min

Target snapshot

Lipoplus + Omegaven (Lipoplus + Omegaven) — General University Hospital, Prague. Lipoplus + Omegaven is a combination intravenous lipid emulsion that provides essential fatty acids and omega-3 polyunsaturated fatty acids for parenteral nutrition support.

Comparator set (1 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Lipoplus + Omegaven TARGET Lipoplus + Omegaven General University Hospital, Prague marketed Intravenous lipid emulsion
ClinOleic + Omegaven ClinOleic + Omegaven General University Hospital, Prague marketed Intravenous lipid emulsion

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Intravenous lipid emulsion class)

  1. General University Hospital, Prague · 2 drugs in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Lipoplus + Omegaven — Competitive Intelligence Brief. https://druglandscape.com/ci/lipoplus-omegaven. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators: